BioViva Sciences Inc., CEO. Entrepreneur
Liz, BioViva Sciences Inc. CEO, is a humanitarian, entrepreneur and innovator, and a leading voice for genetic cures. As a strong proponent of progress and education for the advancement of regenerative medicine modalities, she serves as a motivational speaker to the public at large for the life sciences. She is actively involved in international educational media outreach and sits on the board of the International Longevity Alliance (ILA).
She is an affiliated member of the Complex Biological Systems Alliance (CBSA), which is a unique platform for Mensa based, highly gifted persons who advance scientific discourse and discovery.
The mission of the CBSA is to further scientific understanding of biological complexity and the nature and origins of human disease. She is the founder of BioTrove Investments LLC and the BioTrove Podcasts which is committed to offering a meaningful way for people to learn about and fund research in regenerative medicine. She is also the Secretary of The American Longevity Alliance (ALA) a 501(c)(3) nonprofit trade association that brings together individuals, companies, and organizations who work in advancing the emerging field of cellular and regenerative medicine.
Liz Parrish and Bill Andrews, Ph.D. will present together:
Extending telomeres to reverse the clock of aging and declining health:
Lengthening of telomeres using the enzyme telomerase is a protocol that has demonstrated age reversal in experimental models. Longer telomeres not only increased the energy in old mice, but also restored their ability to breed, restored their brain function, revitalized their internal organs, and made them look and behave young again.
Elizabeth Parrish and Bill Andrews will be discussing their joint venture, called BioViva Fiji, to use gene therapy to make this technology of telomere lengthening possible for humans in the very near future.
Elizabeth Parrish is the Founder and CEO of BioViva USA. She is a humanitarian, entrepreneur and innovator, and a leading voice for genetic cures for aging. Recently she became patient zero in the highly publicized first gene therapy effort to reverse aging.
Bill Andrews, Ph.D. is the Founder and CEO of Sierra Sciences. His scientific background for 35 years in the biotech industry has led to many medical breakthroughs including the discovery of human telomerase. His career for the last 17 years has focused specifically on finding ways to extend human lifespan and health span through the intervention of telomere shortening.